Press Releases

Date	Title	Company
17-Jan-2023	Avectas Launches the Solupore® Platform for the Clinical Manufacturing of Next-Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality	Avectas
17-Jan-2023	ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002	ImmunOs Therapeutics
17-Jan-2023	Pan Cancer T Appoints Dr. Rachel Abbott as Chief Scientific Officer	Pan Cancer T
17-Jan-2023	Industry-First Cancer Screening Technology Boosted by Biomedical Grant Funding	Medicines Discovery Catapult
17-Jan-2023	GPCR Therapeutics Announces Launch of US Phase 2 Trial of GPC-100 in Multiple Myeloma	GPCR Therapeutics
17-Jan-2023	Vésale Bioscience receives €1.8M grant from European Innovation Council for PhageDiag project	Andrew Lloyd Associates
17-Jan-2023	Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan	Kinarus Therapeutics Holding AG
17-Jan-2023	Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom	Relief Therapeutics Holding SA
16-Jan-2023	The Scottish Medicines Consortium recommends Merck’s TEPMETKO® (tepotinib) as the first oral MET inhibitor treatment option for advanced NSCLC adult patients with METex14 skipping alterations	Merck
16-Jan-2023	PharmiWeb.Jobs Welcomes Alexion	Alexion
16-Jan-2023	EverImmune launches phase I clinical trial for its oncobiotic drug candidate in lung and kidney cancer	Andrew Lloyd Associates
16-Jan-2023	CD Formulation Offers 16 types of Food Ingredients as Raw Materials to Manufacture Health Care Products	CD Formulation
16-Jan-2023	Defence Therapeutics Inc.: DEFENCE ACCUMTM ACCEPTED US PATENT TO BOLSTER ITS VACCINE PLATFORM TECHNOLOGY IP	Defence Therapeutics Inc.
16-Jan-2023	BRAIN Biotech AG reports record figures in fiscal year 2021/22 − despite challenging geopolitical environment	BRAIN Biotech AG
16-Jan-2023	Xlife Sciences portfolio company launches project to research a potential therapy for amyotrophic lateral sclerosis (ALS)	Xlife Sciences AG
13-Jan-2023	Tower expands pharmaceutical corridors with new Singapore site	Tower Cold Chain
13-Jan-2023	Rising prevalence of cancer and cardiovascular diseases is driving the sales of Microtome Market \| insightSLICE	insightSLICE
13-Jan-2023	Metabolic Disorders Drugs Market 2023 is estimated to exhibit a CAGR of 7.2% by 2032 \| insightSLICE	insightSLICE
13-Jan-2023	Mammography Market 2023 is anticipated to expand at a CAGR of 9.7% through 2032 \| insightSLICE	insightSLICE
13-Jan-2023	Genitourinary Drugs Market exhibiting CAGR of 2.5% from 2023 to 2032, owing to increasing number of pipeline drugs \| insightSLICE	insightSLICE